Reducing Kidney Toxicity in Cancer Treatment
Author Information
Author(s): E Otsuji, T Yamaguchi, H Matsumura, K Yamamoto, H Tsuruta, Y Yata, H Nishi, K Okamoto, K Kitamura, T Takahashi
Primary Institution: Kyoto Prefectural University of Medicine
Hypothesis
Can the administration of avidin reduce the kidney accumulation of biotinylated chimeric monoclonal antibody Fab fragments conjugated with neocarzinostatin?
Conclusion
The administration of avidin significantly decreases the accumulation of biotinylated chA7Fab and biotinylated chA7Fab-NCS in the kidneys without affecting tumor accumulation.
Supporting Evidence
- The accumulation of biotinylated chA7Fab in the blood and kidneys decreased significantly after the injection of avidin.
- Significant differences in kidney accumulation were observed at 1 and 6 hours after injection.
- The administration of avidin did not affect the tumor accumulation of biotinylated chA7Fab-NCS.
Takeaway
This study found that giving avidin after a special cancer treatment can help protect the kidneys while still allowing the treatment to work on tumors.
Methodology
Nude mice with pancreatic cancer were injected with biotinylated chA7Fab and then given avidin to observe changes in accumulation in blood and kidneys.
Potential Biases
Potential bias in the selection of animal models and the interpretation of results.
Limitations
The study was conducted on a small sample size of mice, and results may not directly translate to human patients.
Participant Demographics
Nude mice bearing human pancreatic carcinoma xenografts.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website